ABBV | ABBVIENYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$286.00
-$2.84 (-0.98%)

ABBVIE (ABBV) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $286.00 vs 50 $270.20 / 200 $237.81
Projection
No cross projected
Test
No active test
Last cross
Golden cross 9 Jul 2026 ยท projected 20 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $294.89 vs 50 $235.80 / 200 $189.47
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 29 Jun 2020 ยท not projected

4-hour as of 3 Nov 13:30 ET

Price
above both $288.53 vs 50 $279.36 / 200 $259.12
Projection
No cross projected
Test
No active test
Last cross
Golden cross 15 Jun 2026 bar 2 ยท projected 18 bars out ยท tested 2 bars

Cross history

37
crosses on record since 2018
19 golden18 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
9 Jul 2026Golden steepdaily20 bars outNot tested
15 Jun 2026Golden4-hour18 bars out2 bar cross test
23 Apr 2026Death moderatedaily30 bars outNot tested
23 Mar 2026Death4-hour19 bars outNot tested
4 Mar 2026Golden4-hour10 bars out3 bar cross test

About ABBV

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$1.2B
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmega

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.